|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Investments, at fair value | ||||||||||||
| Total fixed maturities | ||||||||||||
| Short-term investments | ||||||||||||
| Total investments, at fair value | ||||||||||||
| Investments in Two Sigma Funds, at fair value (cost 2026: $1,574,091; 2025: $1,355,563) | ||||||||||||
| Total investments | ||||||||||||
| Cash and cash equivalents | ||||||||||||
| Restricted cash and cash equivalents | ||||||||||||
| Premiums receivable | ||||||||||||
| Paid losses recoverable | ||||||||||||
| Deferred acquisition costs | ||||||||||||
| Unpaid losses and loss adjustment expenses recoverable | ||||||||||||
| Receivables for investments sold | ||||||||||||
| Prepaid reinsurance | ||||||||||||
| Intangible assets | ||||||||||||
| Other assets | ||||||||||||
| Total assets | ||||||||||||
| Liabilities, non-controlling interest, and shareholders’ equity | ||||||||||||
| Liabilities | ||||||||||||
| Reserve for losses and loss adjustment expenses | ||||||||||||
| Unearned premiums | ||||||||||||
| Reinsurance balances payable | ||||||||||||
| Payables for investments purchased | ||||||||||||
| Term loan, net of issuance costs | ||||||||||||
| Accounts payable and accrued expenses | ||||||||||||
| Payables to related parties | ||||||||||||
| Total liabilities | ||||||||||||
| Non-controlling interest – TS Hamilton Fund | ||||||||||||
| Shareholders’ equity | ||||||||||||
| Common shares: | ||||||||||||
| Common Class A | ||||||||||||
| Common Class B | ||||||||||||
| Common Class C | ||||||||||||
| Total common shares: | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Accumulated other comprehensive loss | ||||||||||||
| Retained earnings | ||||||||||||
| Total shareholders’ equity | ||||||||||||
| Total liabilities, non-controlling interest, and shareholders’ equity | ||||||||||||
| Investments, amortized cost | ||||||||||||
| Total fixed maturities | ||||||||||||
| Short-term investments | ||||||||||||
| Total investments, amortized cost | ||||||||||||
| Investments in Two Sigma Funds, cost |
Loading...